The device has been reported as discarded, therefore no product investigation can be performed, and the customer complaint cannot be confirmed.A manufacturing record evaluation was performed for the finished device 30262212m number, and no internal actions related to the complaint was found during the review.Manufacturer's reference # (b)(4).
|
This event is associated with a clinical trial, sponsored by biosense webster, inc.It was reported that a (b)(6) male patient underwent a paroxysmal atrial fibrillation (afib) ablation procedure with a thermocool® smart touch® sf bi-directional navigation catheter and suffered a cardiac tamponade requiring pericardiocentesis.At the end of the procedure, post ablation and post use of biosense webster, inc.Products, a cardiac tamponade was discovered and confirmed by intracardiac echocardiogram (ice).A pericardiocentesis was performed and 300 cc of fluid was removed from the pericardial space.The patient was reported to be in stable condition after pericardial drainage.Patient¿s outcome is fully recovered with no residual effects and was discharged the following day.Extended hospitalization was not required.The physician was not certain about the timing and the causality of the event and suggested that it can be procedure and/or patient condition related.No error messages were observed on any biosense webster, inc.Equipment during the procedure.Transseptal puncture was performed with a baylis standard curve transseptal needle (71cm) and a baylis nrg e hf 71 c0 transseptal needle.There was no evidence of a steam pop.Flow settings were set to standard flow rates, 2 ml/min and 15 ml/min.Force visualization features used were graph, dashboard, vector and visitag.Visitag parameters for stability used were range 3 mm, time 3 seconds, force over time 30%, tag size 3 gram, and lesion index value (surpoint).
|